𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Fieller's method and net health benefits

✍ Scribed by Daniel F. Heitjan

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
118 KB
Volume
9
Category
Article
ISSN
1057-9230

No coin nor oath required. For personal study only.

✦ Synopsis

Statistical and conceptual difficulties complicate the estimation of the incremental cost-effectiveness ratio (ICER). An alternative approach is to measure cost-effectiveness by the incremental net health benefit (INHB), defined as the difference in mean effectiveness of a new treatment compared with a standard, adjusted for cost difference by subtracting the health foregone if purchasing care at the rate of a marginally cost-effective therapy. Because net health benefit (NHB) is dependent on this threshold rate, one can construct confidence intervals for the INHB at various values of the rate. It turns out that the set of rates where new and standard are not significantly different is equal to the Fieller's method confidence set for the ICER. We review the derivation of the Fieller's method confidence set, present numerical examples, and discuss the implications of our result for the calculation and interpretation of NHB analyses.

πŸ“œ SIMILAR VOLUMES

Discounting and health benefits
Discounting and health benefits
✍ Michael Parsonage; Henry Neuburger πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 528 KB

In each issue of the Journal we shall address an issue of particular concern in the development of health economics and on which there is no consensus within the profession. These articles are published to stimulate debate and to encourage new thinking. Responses are invited in the form of letters t

Statistical determination of cost-effect
Statistical determination of cost-effectiveness frontier based on net health benefits
✍ Eugene M. Laska; Morris Meisner; Carole Siegel; Joseph Wanderling πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 208 KB πŸ‘ 1 views

## Abstract Statistical methods are given for producing a cost‐effectiveness frontier for an arbitrary number of programs. In the deterministic case, the net health benefit (NHB) decision rule is optimal; the rule funds the program with the __largest positive__ NHB at each __Ξ»__, the amount a decis

Postretirement health benefits: Do your
Postretirement health benefits: Do your trend rate estimates significantly affect postretirement costs and reported net income?
✍ Gale E. Newell; Sheldon A. Langsam; Jerry G. Kreuze πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 494 KB

## How important is the accuracy of your health care cost trend estimates? For most companies, the difference between the assumed health care cost trend rate and the actual increase may not largely affect postretirement cost and reported net income. But the authors found that for some companies the

Ratio-based and net benefit-based approa
Ratio-based and net benefit-based approaches to health care resource allocation: proofs of optimality and equivalence
✍ Eugene M. Laska; Morris Meisner; Carole Siegel; Aaron A. Stinnett πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 54 KB πŸ‘ 2 views

Both incremental cost-effectiveness ratios and net benefits have been proposed as summary measures for use in cost-effectiveness analyses. We present a unifying proof of the optimality and equivalence of ICER-and net benefit-based approaches to the health resource allocation problem, including both

Discounting and health benefits: Another
Discounting and health benefits: Another Perspective
✍ John Cairns πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 290 KB

This paper reviews the argument advanced by Parsonage and Neuburger that the non-monetary benefits of health programmes should be discounted at a lower rate than that used for financial flows. The conceptual issues raised in that paper are discussed and others, such as the tradability of non-monetar